StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackJul 21, 2026, 04:32 PM

Lakefront Repurchases 98,648 Shares for €2.56M

AI Summary

Lakefront Biotherapeutics NV announced the repurchase of 98,648 of its own shares between July 13, 2026, and July 17, 2026. This buyback was conducted as part of a program announced on June 9, 2026, through a discretionary mandate to an independent financial intermediary. The total value of the repurchased shares amounted to €2,564,633.73 at an average price of €26.00 per share. Following these transactions, Lakefront holds 511,049 of its own ordinary shares.

Key Highlights

  • Lakefront Biotherapeutics repurchased 98,648 shares.
  • Total value of shares repurchased was €2,564,633.73.
  • Average price paid per share was €26.00.
  • Repurchases occurred between July 13, 2026, and July 17, 2026.
  • Lakefront now holds 511,049 of its own ordinary shares as of July 17, 2026.